| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cancer risk in patients with Parkinson’s disease in South Korea: A nationwide, population-based cohort study
|
Park, Joo-Hyun
|
|
2019
|
117 |
C |
p. 5-13
|
artikel
|
| 2 |
Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series
|
Lemasson, Juliette
|
|
2019
|
117 |
C |
p. 116-118
|
artikel
|
| 3 |
Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy
|
Lee, Chee Khoon
|
|
2019
|
117 |
C |
p. 99-106
|
artikel
|
| 4 |
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer
|
Lindsay, C.R.
|
|
2019
|
117 |
C |
p. 60-68
|
artikel
|
| 5 |
Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials
|
Martín, M.
|
|
2019
|
117 |
C |
p. 91-98
|
artikel
|
| 6 |
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network
|
Soussain, C.
|
|
2019
|
117 |
C |
p. 121-130
|
artikel
|
| 7 |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients
|
Yao, Zong-Han
|
|
2019
|
117 |
C |
p. 107-115
|
artikel
|
| 8 |
In response to Ham et al.: Antibiotics effect on outcome in head and neck cancer
|
Denaro, Nerina
|
|
2019
|
117 |
C |
p. 119-120
|
artikel
|
| 9 |
Long-term excess risk of breast cancer after a single breast density measurement
|
Rebolj, Matejka
|
|
2019
|
117 |
C |
p. 41-47
|
artikel
|
| 10 |
More rationale for optimal sequencing of therapeutic monoclonal antibodies in metastatic colorectal cancer
|
Milano, Gerard
|
|
2019
|
117 |
C |
p. 131-132
|
artikel
|
| 11 |
Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trial
|
Marti, F.E. Marti
|
|
2019
|
117 |
C |
p. 48-59
|
artikel
|
| 12 |
Olaratumab failure in sarcomas: what are the lessons learned?
|
Italiano, Antoine
|
|
2019
|
117 |
C |
p. 69-70
|
artikel
|
| 13 |
Opportunities for improving the efficiency of keratinocyte carcinoma care in primary and specialist care: Results from population-based Dutch cohort studies
|
Wakkee, M.
|
|
2019
|
117 |
C |
p. 32-40
|
artikel
|
| 14 |
Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma
|
Siraj, Abdul K.
|
|
2019
|
117 |
C |
p. 133-144
|
artikel
|
| 15 |
Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup
|
Allodji, Rodrigue S.
|
|
2019
|
117 |
C |
p. 71-83
|
artikel
|
| 16 |
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy
|
Salati, Massimiliano
|
|
2019
|
117 |
C |
p. 84-90
|
artikel
|
| 17 |
The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
|
Mazzarella, Luca
|
|
2019
|
117 |
C |
p. 14-31
|
artikel
|
| 18 |
Treatment in real-life patients with HER2-positive metastatic breast cancer: What we learn from the KAMILLA trial?
|
Criscitiello, Carmen
|
|
2019
|
117 |
C |
p. 1-4
|
artikel
|
Tijdschrift beschrijving